Company Filing History:
Years Active: 2017
Title: Catherine Lippe: Innovator in Microbial Detection
Introduction
Catherine Lippe is a notable inventor based in California, recognized for her contributions to the field of microbial detection. She has developed innovative methods that enhance the identification of extended spectrum beta-lactamases, which are critical in combating antibiotic resistance.
Latest Patents
Catherine holds a patent titled "Methods for the detection and identification of extended spectrum beta lactamases." This patent encompasses compositions designed for the detection and identification of microbes carrying extended spectrum beta-lactamase genes. Specifically, it includes oligonucleotides, probes, and kits for detecting bacterial CTX-M sequences. Additionally, the patent outlines methods for detecting and amplifying microbes that harbor these genes, including CTX-M type extended spectrum beta-lactamase genes. She has 1 patent to her name.
Career Highlights
Catherine Lippe is associated with Geneohm Sciences, Inc., where she applies her expertise in microbial detection. Her work is pivotal in developing solutions that address significant health challenges posed by antibiotic-resistant bacteria.
Collaborations
Catherine collaborates with talented professionals in her field, including Isabelle Duteaud and Celine Roger-Dalbert. Their combined efforts contribute to advancing research and innovation in microbial detection.
Conclusion
Catherine Lippe's work in the detection of extended spectrum beta-lactamases represents a significant advancement in microbiology. Her innovative methods and collaborations continue to impact the field positively.